Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
aesthetics
Pharma
Revance is being bought up by Crown Laboratories for $924M
After treading the commercial path alone for more than a year, Revance, maker of Botox rival Daxxify, has agreed to fly the Crown Laboratories flag.
Fraiser Kansteiner
Aug 12, 2024 2:45pm
AbbVie starts open casting call for next faces of Botox ads
Apr 24, 2024 8:40am
Merz adds another star to its galaxy of Xeomin partners
Mar 6, 2024 9:30am
Galderma tips 6 trends to shape aesthetics in '24 and beyond
Feb 8, 2024 7:59am
Galderma's liquid botulinum toxin bid nixed by FDA
Oct 3, 2023 11:14am
Galderma launches new breast cancer campaign
Oct 3, 2023 9:50am